KRONOX Share Price Target 2035

CAGR-based price projection for Kronox Lab Sciences Limited (KRONOX) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (15.8% CAGR)
Rs 697
2035 Target
Base Case (39.5% CAGR)
Rs 3,720
2035 Target
Bull Case (122.9% CAGR)
Rs 253,050
2035 Target

Current Market Snapshot

CMP: Rs 186.14
52W High: Rs 215.18
52W Low: Rs 124.71
1Y CAGR: 94.6%
3Y CAGR: 39.5%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 216 Rs 260 Rs 415
2028 Rs 250 Rs 362 Rs 925
2029 Rs 289 Rs 505 Rs 2,062
2030 Rs 335 Rs 705 Rs 4,597
2031 Rs 387 Rs 983 Rs 10,247
2032 Rs 449 Rs 1,371 Rs 22,843
2033 Rs 520 Rs 1,912 Rs 50,922
2034 Rs 602 Rs 2,667 Rs 113,515
2035 Rs 697 Rs 3,720 Rs 253,050

Other KRONOX Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the KRONOX share price target for 2035?

Based on historical growth analysis, the KRONOX share price target for 2035 ranges from Rs 697 (conservative) to Rs 3,720 (base case) to Rs 253,050 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of KRONOX?

The current market price of KRONOX (Kronox Lab Sciences Limited) is Rs 186.14. The 52-week high is Rs 215.18 and 52-week low is Rs 124.71.

Is KRONOX a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for KRONOX price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 15.8% CAGR), Base (39.5% CAGR), and Bull (optimistic at 122.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.